# OnCo record nct06198751 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct06198751/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct06198751", "NCT06198751" ;
  schema:name "A Study of Neoadjuvant Treatment With TQB2102 for Injection for Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer"@en ;
  schema:description "A phase 2 trial of TQB2102 in HER2-positive breast cancer, run by Chia Tai Tianqing Pharmaceutical Group Co., Ltd., active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct06198751/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT06198751> ;
  onco:status "active" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2024-02-05" ;
  onco:cancers <https://onco.cc/cancers/breast-her2-positive/>, <https://onco.cc/cancers/her2-positive-early-breast-cancer/> ;
  onco:drugs <https://onco.cc/drugs/tqb2102/> ;
  onco:companies <https://onco.cc/companies/sino-biopharm/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-nct06198751-j-clin-oncol-2026/> .